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Optimization of pluripotent stem cell expansion and differentiation is facilitated by biological tools 
that permit non-invasive and dynamic monitoring of pluripotency, and the ability to select for an 
undifferentiated input cell population.  Here we report on the generation and characterization of clonal 
human embryonic stem (HES3, H9) and human induced pluripotent stem cell lines (UQEW01i-
epifibC11) that have been stably modified with an artificial EOS(C3+) promoter driving expression of 
EGFP and puromycin resistance-conferring proteins. We show that EGFP expression faithfully 
reports on the pluripotency status of the cells in these lines, and that antibiotic selection allows for an 
efficient elimination of differentiated cells from the cultures. We demonstrate that the extinction of 
the expression of the pluripotency reporter during differentiation closely correlates with the decrease 
in expression of conventional pluripotency markers, such as OCT4 (POU5F1), TRA-1-60 and SSEA4 
when screening across conditions with various levels of pluripotency-maintaining or differentiation-
inducing signals. We further illustrate the utility of these lines for real-time monitoring of 
pluripotency in embryoid bodies and microfluidic bioreactors. 
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Human embryonic stem (ES) and induced pluripotent stem (iPS) cells are expected to revolutionize 
regenerative medicine and are potentially powerful tools for therapeutic drug screening (Inoue, H. and 
Yamanaka, S., 2011; Rowntree, R.K. and McNeish, J.D., 2010). Despite recent rapid advances in our 
ability to expand these cells as pluripotent cells (Ungrin, M.D. et al., 2008) and direct their 
differentiation into a range of desired cell lineages (Keller, G., 2005), much is to be learned about the 
extrinsic and endogenous factors produced that control these processes, and how these are modulated 
by cell-cell contact signalling and other features of the microenvironment. The ability to genetically 
manipulate mouse ES cells and the generation of mouse models with constitutive or inducible tissue-
specific, cell-specific or gene-specific fluorescent reporters has greatly accelerated our understanding 
of pluripotent stem cell biology. However, in the case of human pluripotent cells the development of 
such tools has been much slower, mainly because of the inefficient nature of homologous 
recombination in human pluripotent cells, the difficulty in obtaining clonal populations of cells, and 
their inherent genetic and epigenetic instability in culture. The derivation of transgenic, clonal, and 
karyotypically normal human pluripotent stem cell lines is therefore a non-trivial endeavour. 
Furthermore, there is the obvious inability to perform human blastocyst injection of genetically-
tagged ES cells, an assay that is widely used in mice to exemplify the efficacy of ES and iPS cell 
reporters. Given the intrinsic differences between mouse and human ES cells in terms of molecular 
pathways maintaining pluripotency and inducing lineage-specific differentiation, and the need to 
isolate pure populations of lineage-specific progenitors (or the identification of specific cell surface 
markers thereof), a number of laboratories have undertaken the arduous task of genetically tagging 
promoters and genes of interest using either classical homologous recombination or zinc 
finger/TALEN-based genome editing techniques (Liu, Y. et al., 2011; Zou, J. et al., 2009; Zwaka, 
T.P. and Thomson, J.A., 2003). It is, however, becoming increasingly clear that human embryonic 
stem cell lines differ intrinsically in their ability to grow and respond to pluripotent cell culture 
conditions and also possess different biases in their propensity to undergo differentiation into specific 
cell types (Lepski, G., 2012). This is most evident when comparing human iPS cell lines derived from 
different cell types or generated through different methods (Alvarez, C.V. et al., 2012). Understanding 
and harnessing these different propensities of human pluripotent cell lines, properties most likely 
influenced by both genetic background and epigenetic parameters, is one of the major current 
challenges in the stem cell field (Tobin, S.C. and Kim, K., 2012).  
With the recent advent of iPS cells and their wide potential in the field of regenerative medicine, the 
propensity of differentiated, iPS-derived cells to revert back to a pluripotent phenotype is particularly 
topical (Pera, M.F., 2011). Hence, the ability to identify, and ultimately eliminate, the cells that retain 
these undesired pluripotent properties after directed differentiation will be essential for regenerative 
medicine. One of the most viable and attractive approaches to this end is the genetic tagging of cells 
which, in turn, requires the identification of the best promoters capable of reporting on such cells. 
There is thus a clear need for tools that allow for the rapid and facile delivery of gene reporters to 
human pluripotent stem cells that faithfully report on pluripotency and differentiation. Lentiviral 
delivery of fluorescent promoter reporters is clearly an attractive solution, and a family of selectable 
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et al., 2009b). Various promoters have been trialled for their ability to drive expression specifically in 
pluripotent cells, and the artificial OCT4/POU5F1 promoter sequences-based promoter driving 
expression of both EGFP and puromycin N-acetyltransferase (conferring puromycin resistance), used 
in this study, appears to provide the highest efficiency and specificity in human pluripotent ES (hES 
and iPS) cells (Hotta, A. et al., 2009a). Here we report on the generation and verification of the 
pluripotent stem cell lines with the lentivirally-delivered EOS(C3+)-EGFP-IRES-PURO transgene 
that both reports on pluripotency and, of key importance, allows for the selection of pluripotent stem 
cells.  
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2.1 Pluripotent and differentiated cell culture conditions and cell lines 
hES and iPS cells were cultured in feeder-free conditions in xeno-free defined medium, mTeSR
TM
1 
(StemCell Technologies, Vancouver, BC) or NutriStem (Stemgent) on Matrigel™ (BD Biosciences at 
1/100 dilution) coated tissue culture plastic surfaces. NutriStem medium was supplemented with 10 
ng/mL FGF2 (Invitrogen/Life Technologies) for hES and 50 ng/mL for iPS cell line propagation. 
Cells were passaged as clumps using dispase (Gibco/Life Technologies) digestion at 1.5 mg/mL. For 
a typical 2D differentiation protocol, cells were grown in a 6-well plate to ~50% confluence in the 
presence of 2 µg/mL of puromycin, and the medium changed to selection-free KSR medium (Chung, 
T.L. et al., 2010), with or without inducers of differentiation, either 10% FCS or 5 µM retinoic acid 
(RA). Cells were harvested at 2-6 days after induction of differentiation. HES3 and H9 hES cell lines 
were provided by the UQ AIBN StemCore (www.stemcore.com.au). The UQEW01i-epifibC11 iPS 
episomally-derived cell line (referred to as WT11TF for brevity from now on) was described 
previously (Briggs, J.A. et al., 2012; Nayler, S. et al., 2012). At least three independent clones from 
hES and iPS parental cell lines with representative characteristics (levels of reporter expression in 
pluripotent state, reporter inactivation dynamics) were used for analysis.  
2.2 Lentiviral transduction of the pluripotent stem cells 
Lentiviral and packaging vectors, pCMVR8.2 and pVSV-G, were co-transfected into the 293FT cell 
line (Invitrogen) for viral particle production as described in (Whitworth, D.J. et al., 2012). HES3 and 
H9 hES cells adapted to passaging as a single-cell suspension, as described previously (Hudson, J. et 
al., 2012), as well as the hESC and UQEW01i-epifibC11 lines maintained as bulk cultures on 
Matrigel™ substrate(BD Biosciences), were transduced with lentiviral particles and maintained in 
mTeSR
TM
1/Matrigel cultures under selection in the presence of 2.5 µg/mL of puromycin. Putative 
single cell-derived colonies homogeneous for moderate to high EGFP expression were generated from 
HES3 and H9 cell lines and transgene-free iPS clone WT11TF (UQEW01i-epifibC11). The following 
plasmids were obtained from Addgene (MA, U.S.A.) and used for lentivirus production: Addgene 
plasmid 21312  PL-SIN-PGK-EiP, 21313  PL-SIN-EOS-C(3+)-EiP (used to produce the described 
EOS(C3+)-EiP reporter lines), 21314  PL-SIN-EOS-S(4+)-EiP. 
2.3 Analysis of the reporter and pluripotency marker expression 
2.3.1 Flow cytometry: Analysis of cell surface markers was carried out essentially as described in 
(Ovchinnikov, D.A. et al., 2012; Whitworth, D.J. et al., 2012). Briefly, cells were brought to a single 
cell suspension using TrypLE or Cell Dissociation Buffer (Invitrogen) and stained live with anti-
TRA-1-60 1/300 (MAB4360,  Millipore), anti-SSEA4 1/400 (MAB4304, Millipore), anti-TG30 1/400 
(MAB4427, Millipore), or with anti-OCT4 (MAB4419,Millipore) after 10 min fixation in 2% 
neutralized PFA and permeabilization with TritonX-100. For blocking, antibody incubation and 
permeabilization (when applicable) steps, PBS containing 10% heat-inactivated goat serum (Hyclone) 
and 0.1% TritonX-100 (0.4% for permeabilization) was used. For flow cytometry secondary 
antibodies anti-mouse IgG (H+L) AlexaFluor488 or anti-mouse IgM AlexaFluor488 (Molecular 
Probes/Invitrogen, Carlsbad, USA) were used at a 1/1000 dilution. Isotype control antibodies at 
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were collected using BD LSRII or AccuriCFlow C6 cytometers, and analysed using AccuriCFlow. 
2.3.2 Immunofluorescence:  The primary antibodies used for immunofluorescence were: anti-Oct3/4 
(C10, sc5279 SantaCruz) at 1/75, anti-Sox2 (AB5603, Millipore) at 1/100, anti-NANOG (9220 
Millipore) at 1/150. Secondary antibody: anti-mouse IgG (H+L) AlexaFluor488 (Molecular 
Probes/Invitrogen) was used at a 1/1000 dilution. Isotype controls at similar dilutions to the primary 
antibodies were used to assess non-specific binding. No significant labelling was detected in isotype 
control-incubated samples (data not shown). Counter-staining of the nuclei was performed using 
Hoechst 33342 nuclear dye (Invitrogen/Life Technologies) at 0.1 µg/mL in BS.  
2.4 Statistical analysis of the reporter and surface marker correlation 
To correlate the extinction of pluripotency reporter-driven EGFP fluorescence with the surface 
pluripotency markers, flow cytometric analysis was performed on cells from 2D differentiation 
cultures at their intermediate stages: i.e. when the majority of the cells possessed an intermediate level 
of surface marker expression and differentiation phenotype. Fluorescence readings corresponding to 
single-cell events (gated on forward and side scatter plots and peak width) were exported in text 
(*.csv) format using Weasel v2.7 software (WEHI, Melbourne, Australia). Spearman’s rank test 
analysis was performed as described in (McDonald, J.H., 2009). For calculations n>1000 was used, 
thus providing high confidence in the significance of the correlation (p<0.01).  
2.5 Reporter cell line evaluation in multifactorial microbioreactor array-based assays 
Data from full-factorial microbioreactor array screening experiments using a previously described 
system (Hudson, J. et al., 2012) were used to compare EOS-GFP expression with TG30 and TRA-1-
60 expression levels. Briefly, microbioreactors were fabricated and sterilised, surface-coated with 400 
μg/mL purified human fibronectin (BD Biosciences), and seeded with HES3::EOS(C3+)-EiP hESCs 
at ~4×10
4
 cells/cm
2
 in mTeSR
TM
1 without FGF2 and TGF1 (StemCell Technologies) with inclusion 
of 10 μM ROCK inhibitor (Sigma-Aldrich). Cells were allowed to attach for 8-10 h then cultured for 
6.5 d under 60 μL/h continuous fluid flow, under the panel of conditions shown in Figure 3E. At the 
endpoint, arrays were stained for TRA-1-60 and with Hoechst33342, and then imaged with a Zeiss 
LSM 710 laser scanning confocal microscope, with optical sections processed into a maximum 
intensity projection for image analysis. Total fluorescence intensities (TEOS-GFP, for example) were 
extracted from array images with AGScan (https://mulcyber.toulouse.inra.fr/projects/agscan), and 
individual spot intensities in each channel were linearly transformed about the mean and standard 
deviation for all spots in that channel in an individual array, by IEOS-GFP = (TEOS-GFP - μEOS-GFP)/σEOS-GFP, 
where IEOS-GFP is termed the expression index of EOS-GFP, and μEOS-GFP is the mean and σEOS-GFP the 
standard deviation of all spot intensities (TEOS-GFP)for a particular array. 
2.6 Assessment of the differentiation potential of the pluripotency reporter cell lines 
The differentiation potential of EOS(C3+)-EiP cell lines was assessed using both in vitro embryoid 
body formation and in vivo teratoma formation assays. For embryoid body formation, cells were 
digested using dispase with subsequent resuspension in KSR medium (20% KnockOut
TM
 Serum 
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et al., 2010), in a well of a 6-well ultra-low attachment polystyrene plate (Falcon). For the teratoma 
formation assay, a pellet of 5x10
5 
cells was formed in the presence of Matrigel matrix at 1:50 dilution, 
and injected intramuscularly into the thigh muscle of a NOD/SCID mouse. Teratomas were harvested 
within 4-8 weeks, fixed and processed for paraffin embedding and histological analysis. 
Haematoxylin/eosin-stained 5 μm sections were permanently mounted, microscopically analysed and 
imaged on an Olympus IX51 inverted microscope equipped with MicroPublisher 3.3 RTV CCD 
camera (QImaging). For directed differentiation, we utilized previously described protocols for 
neuronal (Briggs, J.A. et al., 2012) differentiation from the hPSCs. 
2.7 Analysis of the pluripotency and lineage-specific marker expression in embryoid bodies derived 
from EOS(C3+)-EiP human pluripotent cell lines 
Downregulation of the expression of the conventional markers of pluripotency (POU5F1 and SOX2) 
and selected markers of differentiation into the three major germ layers and their derivatives (PAX6, 
EOMESODERMIN and CDX2) were assayed using a qPCR-based approach. Briefly, total RNA was 
isolated using the Nucleospin RNA II kit (Macherey-Nagel) according to the manufacturer’s protocol. 
1 μg of isolated total RNA was utilized to synthesize cDNA using the iScript cDNA synthesis kit 
(Bio-Rad) according to the manufacturer’s protocol. qPCR reactions comprised of Ssofast Evagreen 
(Bio-Rad) reaction mix and cDNA template were performed using the C1000 Thermal Cycler (Bio-
Rad). All measured genes had their corresponding quantitative levels normalized to endogenous 
GAPDH. Primer sequences can be found in Table 1. 
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3.1 Generation and characterisation of EOS reporter lines 
Human embryonic stem cell lines HES3 and H9 and the non-viral, integration-free human iPS cell 
line WT11TF (UQEW01i-epifibC11 (Briggs, J.A. et al., 2012)) were cultured under feeder-free 
conditions in mTeSR
TM
1 or MEF-conditioned medium, and transduced with high titre lentiviral 
preparations produced using the EOS(C3+)-EGFP-IRES-PURO (from this time referred to as 
EOS(C3+)-EiP) constructs (Hotta, A. et al., 2009a). By day 5, up to 5 % of hES/iPS cells were found 
to express GFP. Such cultures were next allowed to expand for 3 more days before selection for stable 
integration of the transgene through the addition of initially 2 µg/ml puromycin, with a further 
increase to 2.5 µg/ml puromycin after day 6. After 12-16 days, we observed an almost homogeneous 
expression of EGFP in some colonies of surviving hESC and iPSC (Supplementary figure 1F). These 
colonies were next harvested, expanded and cryopreserved. During continued passaging of 
EOS(C3+)-EIP hES and iPS cells we observed the well-known sporadic inactivation of lentiviral 
transgenes previously observed in hPSCs (Liew, C.G. et al., 2007; Xia, X. et al., 2007), as indicated 
by the “salt-and-pepper” pattern of EGFP–expressing cells interspersed with those that have lost the 
expression (best illustrated in Supplementary Figure 1C), most likely due to epigenetically-driven 
lentiviral transgene inactivation. However, the addition of puromycin to such cultures allowed facile 
deletion of the vast majority of such cells (Supplementary Figure 1C, L, also discussed further in 
section 3.3). Clones displaying highly-homogeneous and penetrant expression of the reporter 
transgene were picked for further characterisation (Figure 1B, F, H and Supplementary Figure 1G-I). 
EOS(C3+)-EIP lentivirally-transduced hESC and iPSC were expanded for more than 20 weekly 
passages and exhibited normal karyotypes (Supplementary figure 1) and expressed high levels of the 
pluripotency-controlling transcription factors POU5F1/OCT4, SOX2 and NANOG (Figure 2A) by 
immunofluorescence and Oct4 and SOX2 by FACS (Table 2). When under constant selection, the 
fraction of EGFP-expressing resistant cells in single cell-derived clones was found to be consistently 
high in all hPSCs, specifically 90.14 ± 3.2% (5 clones) for HES3 hESC and 93.5 ± 2.7% (5 clones) 
for WT11TF iPSC (also see Table 1). The pluripotency of stable EOS lines was confirmed by RT-
PCR analysis of embryoid bodies (EBs), which demonstrated expression of markers of all three germ 
layers and their derivatives (Supplementary figure 2). Furthermore, both hESC and iPSC EOS lines 
formed teratomas in NOD-SCID mice that exhibited cell types representative of the three germ layers 
(Figure 2 E-G for hESC- and Supplementary figure 2 for iPSC-derived EOS clones). In situ analysis 
of GFP expression in cultured hESC and iPSC lines indicated an excellent correlation between the 
loss of EGFP fluorescence and morphological signs of differentiation (Fig 1 I-J), such as those 
typically occurring at the centres of hES and iPS colonies.   
3.2 Enrichment for pluripotent cells improves directed differentiation protocols 
Because differentiated cells excrete paracrine factors and impose confounding cell-cell interactions on 
human pluripotent stem cells, homogeneous and efficient differentiation protocols generally require 
(or at least greatly benefit from) a pure pluripotent starting population, e.g. (Hudson, J. et al., 2012). 
The presence of the EOS promoter-driven puromycin antibiotic selection marker allows for a rapid 
deletion of any differentiated cells from such cultures (e.g. Fig 1K where the EGFP-IRES-puro 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPTcassette is driven by a ubiquitous PGK promoter compared to a colony in Fig 1L utilising the 
EOS(C3+) promoter). Nearly-complete ablation could be achieved in as little as 2-3 days due to the 
potent nature of the puromycin selection, causing rapid death and detachment of non-resistant cells 
(Supplementary Figure 1L and data not shown). 
To exemplify the benefits of this selection, we cultured three WT11TF::EOS(C3+)-EiP clones for 3 
weeks in parallel in conditioned medium containing 50 ng/mL bFGF with and without puromycin 
selection. Subsequent flow-cytometric analysis showed that the antibiotic-selected population 
contained 1.7 ± 0.5% of POU5F1/OCT4
-
 cells (N=3) while the similarly cultured non-selected 
populations contained 9.3 ± 2.3% (N=3) POU5F1/OCT4
-
 cells (Figure 2H). We next assessed whether 
this difference in starting population affects the efficiency of neuronal differentiation (See Methods 
section). Indeed, after 6 days of directed neuronal differentiation, puromycin-selected cultures 
displayed 31 ± 4.2% PAX6+ neuroepithelial progenitors, as measured by flow cytometry with anti-
PAX6 antibody, whereas unselected cultures show 20 ± 5.1% PAX6+ cells (N=3, Figure 2H and 
Supplementary Figure 2D).  
3.3 Validation of the functionality of the pluripotency reporter lines 
In time-lapse videos of differentiating colonies of the reporter clones a very good concordance 
between the EGFP extinction and morphological changes associated with differentiation is apparent 
(Supplementary videos 1-3), with central areas of colonies inactivating the reporter and acquiring a 
differentiated morphology first. Complete extinction of reporter fluorescence was observed after 6 
days of withdrawal of the pluripotency-maintaining factors, addition of foetal calf serum (FCS) or 
supplementation with retinoic acid at 5 µM (Figure 3A). 
Since the conventional variant of the EGFP protein was used in the construction of the transgene it 
was important to verify the dynamic response range and kinetics of EGFP downregulation during 
differentiation of the reporter lines in comparison with the expression of other widely-used 
pluripotency markers. To this end we allowed reporter-containing hESC and iPSC to undergo 
spontaneous differentiation, through the withdrawal of FGF and TGF from the culture medium, or 
induced differentiation through addition of retinoic acid to the medium, and assessed EGFP and 
pluripotency marker expression at days 0, 2, 4 and 6. Downregulation of EGFP occurred more rapidly 
and more completely than downregulation of the widely-used pluripotency markers TRA-1-60, TG30 
and SSEA4 (Figure 3C, D, Supplementary Figure 3B, C), and correlated very closely with the 
downregulation of OCT4 expression (Figure 3C, Supplementary Figure 3C) for both hESC-(Figure 3) 
and iPS-derived (Supplementary Figure 3) reporter clones. Downregulation of the reporter followed 
the decrease in levels of OCT4 protein with a ~24 hours lag period resulting in a population of cells 
with reduced OCT4 expression but still retaining detectable levels of EGFP reporter protein 
expression (Figure 3C). This observation is consistent with the stability of the EGFP mRNA (Cubitt, 
A.B. et al., 1995), the half-life of EGFP protein of around 26 hours in mammalian cells (Corish, P. 
and Tyler-Smith, C., 1999) and the fact that OCT4 is itself is a direct regulator of the reporter 
promoter.  
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pluripotency cell surface markers such as TRA-1-60 and SSEA-4 (representative raw data plots 
shown for TRA1-60 in Figure 3B, and for SSEA4 in Supplementary Figure 3A). The Spearman’s 
rank-based test is most suitable for assessment of general trends of this type, as it is not based on any 
assumption of the nature of the sample’s distribution. The correlation appeared to be very good with 
Spearman’s rho values ≥0.7 for EGFP and surface markers, >0.8 for TRA-1-60 (rs=0.81 ± 0.9%, n=3) 
and rs >0.7 for SSEA4  (Supplementary Figure 3A and data not shown).  
Collectively these data demonstrate that EGFP expression in lentivirally-generated hESC and hiPSC 
EOS(C3+)-EiP pluripotency reporter lines faithfully and dynamically reports on pluripotency and that 
such lines behave as normal human pluripotent cell lines. 
3.4 Pluripotency screening in a multifactorial microbioreactor array 
The pluripotency reporter cell line HES3:EOS-C(3+)-EiP was seeded into the microbioreactor array 
(Titmarsh, D.M. et al., 2013) and subjected to factorial combinations of the pluripotency maintenance 
factors FGF2 and TGFβ1 and the differentiation-inducing factor retinoic acid (RA) using the 
concentrations listed in the panel in Figure 3E. After continuous slow perfusion culture for 6.5 days 
under these conditions, cells had proliferated and showed morphological differences between various 
treatments, and expressed GFP under the control of the EOS(C3+)-EIP promoter construct. GFP 
expression in the HES3::EOS-C(3+)-EiP reporter line exhibited a high dynamic range (bright 
expression and efficient extinction) and sensitive response. The presence of 5 or 10 μM RA reduced 
EOS(C3+)-EIP expression to a baseline level regardless of FGF2 or TGFβ1 treatment. Also, 
treatments lacking maintenance factors (FGF2 and TGFβ1, Column 1) or with insufficient factors 
(0.25 ng/mL TGFβ1, Column 4) had similar EOS(C3+)-EIP expression to RA-treated conditions, 
showing sensitivity to absent or insufficient pro-maintenance signals. Supply of sufficient 
maintenance factors (column 25, for example) maintained high-level expression. The highest response 
for all 3 pluripotency markers occurred at Column 25 (100 ng/mL FGF2, 0.5 ng/mL TGFβ1), which 
corresponds to reconstituted composition of original mTeSR
TM
1 maintenance medium. 
TRA-1-60 exhibited a lower dynamic range than EOS(C3+)-EIP, and had higher residual expression, 
resulting in “false-positive” readouts in pluripotency non-maintaining environments in some 
differentiating conditions in the array (Figure 3D and figure legend, and Figures 3C and 
Supplementary Figure 2). As a result of this, levels of TRA-1-60 expression, both when normalized 
across the microbioreactor (Figure 3E) or against the chamber’s DNA contents (data not shown), 
varied more widely than EOS(C3+)-EIP and thus were less sensitive as an indicator of differentiation, 
while the reporter expression appeared to correlate well with the conditions favouring maintenance of 
pluripotency, and showed  robust down-regulation in all RA-containing environments (Figure 3E).  
3.5 Persistence of the EOS(C3+)-EIP reporter uncovers heterogeneity amongst embryoid bodies in 
differentiation assays 
To investigate extinction dynamics of the pluripotency reporter in a 3D setting, we next subjected 
hESC and iPSC reporter lines to embryoid body (EB) differentiation protocols. Conventional analysis 
of lineage-specific marker expression on pooled EBs after 8 weeks shows the expected overall 
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TUBB3), posterior endoderm (CDX2) and mesoderm (EOMESODERMIN) lineage markers that is 
routinely reported in the literature (Supplementary figure 2). However, in situ examination of EGFP 
expression in EOS(C3+)-hESC and iPSC reporter clone derived suspension EBs revealed an 
unexpected persistence and remarkable inter-EB diversity (Figure 4 A-F). While there was a marked 
and expected overall downregulation of reporter expression after 2 weeks in culture when compared 
to freshly generated EBs (Figure 4C), a large proportion of the EBs retained low levels of EGFP 
expression (Figure 4C,C’). After 6 weeks of suspension culture in KSR medium without pluripotency-
maintaining factors a number of EBs (~70%, increasing with time in culture) lost all, or most, of the 
EOS(C3+)-EIP reporter-driven EGFP fluorescence (Figure 4F). These EBs were typically smaller, 
and started to form cavities or cyst-like structures (Supplementary Figure 4B,C). Pooling of the 6 
week-old EGFP-low and EGFP-negative EBs followed by a qPCR analysis revealed that EBs 
retaining reporter fluorescence maintained higher levels of residual OCT4/POU5F1 (tested using 2 
distinct qPCR primer sets), its downstream target LEFTYA, and higher levels of the mesodermal 
marker EOMESODERMIN (Supplementary Figure 4A).  On the other hand, low EGFP-expressing 
EBs showed similar expression levels of SOX2 (a direct regulator of the EOS promoter, also tested 
using 2 distinct qPCR assays, one of which is shown in Supplementary Figure 4A), DNMT3A (a 
pluripotency-associated DNA methyl-transferase), PAX6 (a neuroectodermal marker) and  TUBB3 (a 
neuronal marker) (Supplementary Figure 4A). By week 12 virtually no EGFP expression was detected 
in any of the EBs (Figure 4F, Supplementary Figure 4C,D), indicating that this persistence of EGFP 
expression in a subset of 6 week-old EBs that appears to undergo mesodermal differentiation is not 
due to an intrinsic inability to down-regulate the reporter.  Identification of this unexpected 
heterogeneity within EB pools would not have been possible without the use of the pluripotency 
reporter and is one example of its utility. 
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The ability for live monitoring of the pluripotency status of stem cells is important for both 
optimisation of growth and differentiation conditions, and assessment of the retention and extinction 
of pluripotency by stem cell lines, in particular iPSCs, during differentiation. The EOS promoter 
tested is available in 2 variants, with tandemly concatenated OCT4/SOX2 binding sites derived from 
either the OCT4/POU5F1 promoter (C3, 3 copies) or SOX2 promoter (S4 variant, 4 copies) (Hotta, A. 
et al., 2009a; Hotta, A. et al., 2009b). Clonally-derived hES lines were originally generated using both 
variants, but preliminary analysis showed that the former (C3+) variant  tended to produce lines with 
more consistent reporter expression and responsiveness across a wider range of basal fluorescence 
levels, and produced a larger fraction of puromycin-resistant clones that were EGFP
+
 (78%  vs. 62%, 
n=50 for HES3).  
It is likely that a pluripotency reporter construct could be a useful tool to drive “suicide gene”-based 
cassettes and delete unwanted stem cells that either retain or re-acquire pluripotency in iPSC-derived 
grafts. In this study we show that the reporter is rapidly extinguished during various directed and 
spontaneous differentiation protocols, with more efficient extinction in neurally-biased embryoid 
body differentiation, but can maintain residual expression for extended periods in cells that 
differentiate into embryoid bodies biased towards the mesodermal lineage. Reporter expression is 
eventually lost in the majority of cellular aggregates (EBs) after 6 weeks and from all cells after 12 
weeks of EB-based differentiation, identifying the time window when such deletion strategies should 
commence in vivo. One could further envisage that the lentiviral delivery of the reporter to newly 
generated iPS cell lines could be used as a tool to screen such lines for their propensity to re-acquire 
pluripotency following differentiation, e.g. as EBs, and study the molecular basis of this unwanted 
property. 
In the shorter term the greatest utility of these lines lies in their ability to report on 
pluripotency in real time. We exemplify that human pluripotent stem cell lines that stably express the 
reporter allow monitoring of the pluripotency states of individual cells in a wide spectrum of 
experimental settings (e.g. Titmarsh, D.M. et al., 2013). These lines are particularly valuable for 
microbioreactor arrays, bioengineering applications, and other applications requiring non-intrusive 
and continuous monitoring regimes such as screening of culture surfaces. 
 The reporter lines allowed us to observe in real time that colonies with greater than 300 cells 
displayed slightly higher expression levels of the reporter at the colonies’ outermost few cell layers 
(Figure 1A, F, fluorescence profiles across colonies shown in Supplementary figure 2M). This is in 
agreement with previous observations of higher levels of TGF/activin signalling and higher 
expression of pluripotency markers on the edges of the human pluripotent stem cell colonies (Hough, 
S.R. et al., 2009). 
 The ability to efficiently select for cells of a consistently highly-pluripotent phenotype in cultures, 
including those on a large scale, is crucial for providing homogeneously-pluripotent starting material 
for directed differentiation protocols, for instance in the generation of cardiomyocytes and certain 
neuronal cell types. 
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differentiated, OCT4-negative cells (Figure 2H). It appears that these spontaneously-differentiated 
cells have a cell non-autonomous effect on the directed neuroepithelial conversion of the whole 
population, resulting in a 33% drop in the numbers of neuroectodermally-converted cells as measured 
by the expression of PAX6 protein (Figure 2H and Supplementary Figure 2D).  
The difference in correlation between EGFP and TRA160 as compared to that between EGFP and 
SSEA4 or TG30 is consistent with the observations that extinction dynamics of TRA-1-60 with 
differentiation are substantially faster than that of TG30 or SSEA4 (Figure 3D and supplementary 
figure 2). The dynamic response range and sensitivity of the EOS(C3+)-EGFP-IRES-Puro reporter is 
in fact superior to TRA-1-60, as can be judged from the more rapid and pronounced downregulation 
of EGFP than TRA-1-60 following RA-induced differentiation (Figure 3D and Supplementary Figure 
2C). Similarly, when titrating concentration combinations of FGF2 and TGF1, the expression of 
reporter EGFP corresponded much more dynamically to variations in these pluripotency-maintaining 
factors than TRA-1-60 (Figure 3E).  
In conclusion we have generated and characterized multiple hES and iPS cell lines that should prove a 
useful tool for exploration of the maintenance of pluripotency, pluripotency extinction and re-
emergence in real time, enabling simple and scalable selection of hPSC populations that are near 
homogeneously pluripotent, and undergo more homogeneous and efficient directed differentiation . 
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Figure 1.Cellular distribution of reporter fluorescence in the EOS promoter-based reporter 
lines grown in feeder-free conditions. A,B - Corresponding phase-contrast and EGFP 
epifluorescence images of a HES3 hES cell line-based EOS(C3+)-EiP colony grown under puromycin 
selection. C,D - Flow cytometry histograms illustrating consistently high levels of EOS(C3+)-EiP 
expression in 3 puromycin-selected HES3 EOS(C3+) clones. Parental cell line HES3 (orig), was used 
as a control. E,F Phase contrast and epifluorescence images of a typical H9 hES EOS(C3)-EiP 
colony. G,H - Images of the transgene-free iPS line UQEW01i-epifibC11-based EOS(C3+)-EiP cell 
line colony. (A,B and E-H are all passage 2 after transduction and continuous puromycin selection)  
I,J - phase-contrast and epifluorescence images of the iPS (UQEW01i-epifibC11) EOS(C3+)-EiP cell 
lines’ colonies following partial spontaneous differentiation in their central portions. Prominent drop 
in the reporter fluorescence correlates with morphological signs of differentiation. K,L- phase-
contrast images of the edges of HES3::PGK-EiP (K) and HES3::EOS(C3+)-EiP (L) colonies, 
respectively, grown in presence of 2µg/mL of  puromycin, illustrating efficient elimination of 
fibroblast-like differentiated cells from the colony’s edges in EOS(C3+)- but not in the ubiquitous 
PGK promoter-driven EGFP and puromycin HES3 line. Scale bars = 20µm. 
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Figure 2. Validating pluripotency and differentiation potential of the EOS(C3+)-EIP 
pluripotency reporter in hESC and iPSC lines, and their utility in improving directed 
differentiation. A. An immunofluorescent staining for OCT4/POU5F1 and SOX2 in representative 
HES3::EOS(C3+)-EiP colonies grown under puromycin selection. Scale bar=20µm. B-D. Flow-
cytometric analysis of EGFP reporter and surface marker expression (SSEA4 and TRA-1-60) in a 
HES3 EOS(C3+)-EiP hES cell line grown for 1 day without selection. E-G. Histological teratoma 
sections derived from HES3::EOS(C3+)-EiP cell line, demonstrating fully-differentiated tissues 
derived from the three germ layers: mesoderm (E, cartilage), ectoderm (F, retinal pigmented 
neuroepithelium-like) and endoderm (G, secretory epithelium and goblet-like cells lining a mucus-
filled cavity, *). Hematoxylin/eosin staining on 5 µm-thick paraffin sections, scale bar 100 µm. H, 
Flow cytometric analysis of the difference in loss of pluripotency marker POU5F1/OCT4, and  
subsequent acquisition of expression of the neuroepithelial marker PAX6 in iPS-derived reporter 
clone grown with (green) and without (blue) selection. 
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Figure 3. Utility of the EOS(C3+)-EiP reporter lines for assessment of the pluripotency status. A. 
Histogram of the distribution of reporter fluorescence levels illustrating effects of various 
differentiation-inducing conditions on the expression of the reporter in HES3::EOS(C3+). B. Plot 
illustrating the correlation between EGFP fluorescence and TRA1-60 expression in HES3::EOS(C3+)-
EiP after 3 days of FCS-induced differentiation as measured by flow cytometry. Only 300 events (for 
visual clarity) were plotted on a double decimal logarithm scale plot.  Spearman’s rho coefficient for 
this plot rs= 0.82. C. Contour-plots of the flow-cytometric measurements illustrating kinetics of the 
decrease in OCT4 and EGFP expression in differentiating HES3::EOS(C3+)-EiP. D. Histograms 
illustrating dynamics of OCT4,EGFP, TRA1-60 and TG30 extinction in a HES3::EOS(C3+)-EiP clone 
during the time course of differentiation in the KSR medium E. Expression indices (see Methods, and 
(Titmarsh, D.M. et al., 2013) for definition) of EOS(C3+)-EIP reporter and TRA-1-60 in 
microbioreactor during factorial analysis of the effects of FGF2, TGFβ1 and RA concentration on 
maintenance of pluripotency in a HES3 reporter cell line. Reporter and surface marker fluorescence 
reading for each of the wells was normalized against DNA content. Fluorescence indices are plotted as 
mean ± SD. 
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ACCEPTED MANUSCRIPTFigure 4. Use of the EOS reporter reveals heterogeneity within pools of spontaneously-
differentiating embryoid bodies (EBs). A. Fluorescent image of representative EBs 2 days after 
formation. B. EBs 1 weeks after formation retain high levels of EOS(C3+)-EiP reporter fluorescence. 
C, C’. Fluorescent and bright-field images of EBs 2 weeks into differentiation, when a number of EBs 
(<10%) fully inactivate the reporter. D, D’. Representative images of both types of EBs at 6 weeks of 
differentiation that clearly retain (EGFP+) or extinguish (EGFP-) the reporter expression in majority 
of their cells, and were used for the differential expression analysis. E, E’. By 8 weeks, only low level 
of EGFP expression persists in some of the EBs, and virtually all expression is lost by week 12 (See 
Supplementary Figure 4). F. Representation of the quantification of EGFP+ and EGFP- fractions in 
iPSC- reporter derived EBs. Scored EB number N>40 for each time point. G. qPCR analysis of the 
expression of pluripotency marker POU5F1/OCT4, and mesodermal (EOMESODERMIN) and 
neuroepithelial (PAX6) markers in EGFP
+
 and EGFP
-
 EBs at 6 weeks. Persistence of EGFP correlates 
with high levels of residual POU5F1/OCT4 expression. See Discussion for more detail. Data for all 
genes is normalised against the internal GAPDH control, error bars-SEM values (N=3). Scale bar = 
500µm. 
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Figure 4 
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ACCEPTED MANUSCRIPTTable 1. Gene targets and their corresponding primer sequences utilized for qPCR 
analysis. 
Gene Target Forward Primer Reverse Primer
POU5F1 TGAAGCTGGAGAAGGAGAAG ATCGGCCTGTGTATATCCC
SOX2 CCACCTACAGCATGTCCTACTCG GGGAGGAAGAGGTAACCACAGG
CDX2 GGAGCTGGAGAAGGAGTTT TGATTTTCCTCTCCTTTGCTC
PAX6 CAGCACCAGTGTCTACCAACCA CAGATGTGAAGGAGGAAACCG
EOMES CAAATTCCACCGCCACCAAACTGA TTGTAGTGGGCAGTGGGATTGAGT
GAPDH ATGGGGAAGGTGAAGGTCG TAAAAGCAGCCCTGGTGACC
SOX17 GGCGCAGCAGAATCCAGA CCACGACTTGCCCAGCAT
SOX2-2 GCTACAGCATGATGCAGGACCA TCTGCGAGCTGGTCATGGAGTT
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Table 2. Characterisation of stable  EOS(C3+)-EiP hPSC clones used in this study 
Cell type Cell line Clone Karyotype 
% 
EGFP
+* 
% 
OCT4
+*
 
% 
TRA1-
60* 
NANOG
+
(IF
¥
) 
hES 
HES3 
3.1 Normal ♀ 91.2 97.1 97.9 Yes 
3.2 Normal ♀ 89.7 96.9 98.2 Yes 
3.3 N/A 86.8 96.2 98.0 Yes 
H9 
#1 Normal ♀ 91.7 96.7 97.1 Yes 
#2 Normal ♀ 94.2 98.6 99.3 Yes 
#3 Normal ♀ 92.3 99.3 98.4 Yes 
iPS WT11TF 
#1 Normal ♂ 93.8 98.1 98.9 Yes 
#2 Normal ♂ 94.1 98.3 97.9 Yes 
#3 Normal ♂ 92.3 97.8 98.4 Yes 
 
* in cultures kept under continuous selection with  2µg/mL puromycin for 2 
weeks 
¥  >95% positive by immunofluorescent staining for nuclear NANOG protein 
N/A not available  
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 stable selectable pluripotency reporter lines in hES and transgene-free iPS cells 
 more sensitive pluripotency readout than conventional surface markers 
 pluripotency enrichment facilitates directed differentiation protocols 
 reveals heterogeneity in conventional embryoid body assays 
